🌎 Ship to: United States
Toggle Nav
Cart
Search
Same-day shipping on all in-stock items.
Advanced Search
Quick Order SDS CoA
Menu
Account
Settings
྾
224,000+ research products · Triple ISO certified · COA & SDS available for every product · Same-day shipping on in-stock items

Rituximab (anti-CD20) - Primary antibody, BINDING AGENT of B-lymphocyte antigen CD20 binding agent, BINDING AGENT of B-lymphocyte antigen CD20 binding agent

CAS: 174722-31-7 Cat. No.: R412001 EC Number: 695-706-4 PubChem CID: 168009840
COA
Rituximab (anti-CD20) - Primary antibody, BINDING AGENT of B-lymphocyte antigen CD20 binding agent, BINDING AGENT of B-lymphocyte antigen CD20 binding agent
AVAILABLE TO ORDER
GRADE & PURITY Animal Free ? Animal-free — produced without animal-derived components to reduce contamination risk. Use in biomanufacturing and culture avoiding animal-origin material. ≥97% See COA
Application
Flow Cytometry
Host species
Human
Reactive species
Human
Isotype
Human IgG1
Conjugation
Unconjugated
★
 ·  off list, applied to all prices below.
Size
Status
Price
Qty
1mg
R412001-1mg
1-2 wks(?)
Item is derived from our semi-finished stock and is processed in 1-2 weeks.
$339.90
5mg
R412001-5mg
1
$1,133.90
10mg
R412001-10mg
1
$1,799.90
25mg
R412001-25mg
1-2 wks(?)
Item is derived from our semi-finished stock and is processed in 1-2 weeks.
$2,686.90
Enter a quantity for the sizes you want to add.
Bulk / Custom
♡ Wish List ⇅ Compare ⎙ Print page
SDS
Safety data
COA
Certificate
DS
Datasheet
SP
Spec sheet
Overview Specifications Storage and Shipping Documentation Advanced Data Associated Targets(Human) Mechanisms of Action Certificates（CoA,COO,BSE/TSE and Analysis Chart) Solution Calculators Reviews
🧪

Why this grade

Animal Free, ≥97%, See COA Animal Free for sensitive chromatographic and analytical workflows requiring minimal baseline interference.

🌡

Storage & shipping

Protected from light,Store at -20°C Ships Ice chest + Ice pads Check lot-specific COA for exact specifications.

📋

Quality documents

SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.

📚

Literature proof

Cited in 0 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.

Overview

Information

Rituximab (anti-CD20) Rituximab (anti-CD20) is a chimeric anti-CD20 mAb that binds the CD20 antigen on B cells with a binding affinity of 5 nM, MW: 143.86 KD.

Specifications

Product Name
Rituximab (anti-CD20) - Primary antibody, BINDING AGENT of B-lymphocyte antigen CD20 binding agent
Synonyms
IDEC-C2B8
Specifications & Purity
Animal Free, ≥97%, See COA
Host species
Human
Conjugation
Unconjugated
Grade
Animal Free
Action Type
BINDING AGENT
Mechanism of action
BINDING AGENT of B-lymphocyte antigen CD20 binding agent
Light Chain Type
kappa
Concentration
See COA
CAS
174722-31-7
Storage and Shipping
Storage
Protected from light,Store at -20°C
Shipped In
Ice chest + Ice pads
Stability And Storage
Store at -20℃ for two years. Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle.

Documentation

📋 Safety Data Sheet (SDS)

Comprehensive hazard, handling, storage, and regulatory compliance document.

Download SDS →

✅ Certificate of Analysis (COA)

Lot-specific quality data. Enter your lot number to retrieve the exact COA.

Look up COA →

📊 Datasheet

Quick-reference summary of product specifications and applications.

View datasheet →

🔬 Specification Sheet

Full quality attributes and acceptance criteria for this grade.

View spec sheet →

Advanced Data

Associated Targets(Human)
MS4A1 Tclin B-lymphocyte antigen CD20 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
Mechanisms of Action
Certificates（CoA,COO,BSE/TSE and Analysis Chart)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

3 results found

Lot NumberCertificate TypeDateItem
ZJ23F0300042Certificate of AnalysisMar 14, 2023 R412001
ZJ23F0300043Certificate of AnalysisMar 14, 2023 R412001
ZJ23F0300044Certificate of AnalysisMar 14, 2023 R412001
Solution Calculators
Reviews

Customer Reviews

Need help choosing the grade?

Our grade selection guide covers purity, stabilizer status, and application suitability for all variants in our catalog.

View Animal Free grade guide →
Bulk & Custom Packaging Need larger quantities or custom specifications? Contact our team for a tailored quote.

View related series

Click to view target information: MS4A1
 Accession#:P11836 (48) CD20 (48) Gene ID:931 (47) Immunology/Inflammation (1939) MS4A1 (48)

Related Products

Obinutuzumab (anti-CD20) - Primary antibody, for ELISA,Functional Assay,Flow cytometry,Kinetics (BLI),Kinetics (SPR) various applications, specific to MS4A1, >95%, Human IgG1, Antibody of CD20 (membrane-spanning 4-domains; subfamily A; member 1)
Recombinant CD20 Antibody (PerCP) - Primary antibody, for Flow various applications, from Human, generated in Human, specific to Human CD20 / MS4A1, Human IgG1
Recombinant CD20 Antibody (Biotin) - Primary antibody, for Flow various applications, from Human, generated in Human, specific to Human CD20/MS4A1, Human IgG1
Recombinant CD20 Antibody (APC) - Primary antibody, for Flow various applications, from Human, generated in Human, specific to Human CD20 / MS4A1, Human IgG1
Recombinant CD20 Antibody (FITC) - Primary antibody, for Flow various applications, from human, generated in Human, specific to Human CD20 / MS4A1, Human IgG1
Recombinant CD20 Antibody (PE) - Primary antibody, for Flow various applications, from Human, generated in Human, specific to Human CD20 / MS4A1, Human IgG1
Ofatumumab (anti-CD20) - Primary antibody, for ELISA,Functional Assay,Kinetics (BLI),Kinetics (SPR),Flow Cyt various applications, specific to MS4A1, >95%, Human IgG1, BINDING AGENT of B-lymphocyte antigen CD20 binding agent
Veltuzumab (anti-CD20) - Primary antibody, specific to MS4A1, Human IgG1, Antibody of CD20 (membrane-spanning 4-domains; subfamily A; member 1)
Ublituximab (anti-CD20) - Primary antibody, specific to MS4A1, >95%, Human IgG1, Antibody of CD20 (membrane-spanning 4-domains; subfamily A; member 1)
Ocrelizumab (anti-CD20) - Primary antibody, specific to MS4A1, >95%, Human IgG1, Antibody of CD20 (membrane-spanning 4-domains; subfamily A; member 1)
Divozilimab (anti-CD20) - Primary antibody, specific to MS4A1, >95%, Human IgG1
Ocaratuzumab (anti-CD20) - Primary antibody, specific to MS4A1, >95%, Human IgG1, BINDING AGENT of B-lymphocyte antigen CD20 binding agent
Ripertamab (anti-CD20) - Primary antibody, specific to MS4A1, Human IgG1
CD20 Mouse mAb - Primary antibody, specific to CD20, Mouse IgG2b
TRU-015 (anti-CD20) - Primary antibody, specific to MS4A1, Human IgG1
Ibritumomab (anti-CD20) - Primary antibody, specific to MS4A1, Human IgG1
CD20 Mouse mAb (APC) - Primary antibody, specific to CD20, Mouse IgG2b
CD20 Mouse mAb (FITC) - Primary antibody, specific to CD20
CD20 Mouse mAb (Biotin) - Primary antibody, specific to CD20
CD20 Mouse mAb (AF700) - Primary antibody, specific to CD20
CD20 Mouse mAb (AF647) - Primary antibody, specific to CD20
Recombinant CD20 Antibody - Primary antibody, specific to Human CD20
Recombinant CD20 Antibody (AF405) - Primary antibody, specific to MS4A1
Recombinant CD20 Antibody (AF700) - Primary antibody, specific to MS4A1
Recombinant CD20 Antibody (AF647) - Primary antibody, specific to MS4A1
Recombinant CD20 Antibody (Biotin) - Primary antibody, specific to MS4A1
We use cookies to ensure the website functions properly and, where permitted, to improve your experience. You can manage your preferences at any time in Settings. Learn more in our Cookie Policy.

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.

Privacy Policy Terms of Use Cookie Policy Terms and Conditions of Sale Sales Policy
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.
Copyright © 2023–present Aladdin Scientific Corp. All rights reserved.